239 related articles for article (PubMed ID: 8190113)
21. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
22. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
Ehlert FJ
J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
[TBL] [Abstract][Full Text] [Related]
23. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
Redka DS; Pisterzi LF; Wells JW
Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
[TBL] [Abstract][Full Text] [Related]
24. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
Lee SY; Zhu SZ; el-Fakahany EE
Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
[TBL] [Abstract][Full Text] [Related]
25. Two allosteric modulators interact at a common site on cardiac muscarinic receptors.
Ellis J; Seidenberg M
Mol Pharmacol; 1992 Oct; 42(4):638-41. PubMed ID: 1435741
[TBL] [Abstract][Full Text] [Related]
26. A novel multivalent ligand that bridges the allosteric and orthosteric binding sites of the M2 muscarinic receptor.
Steinfeld T; Mammen M; Smith JA; Wilson RD; Jasper JR
Mol Pharmacol; 2007 Aug; 72(2):291-302. PubMed ID: 17478612
[TBL] [Abstract][Full Text] [Related]
27. Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions.
Ellis J; Seidenberg M; Brann MR
Mol Pharmacol; 1993 Sep; 44(3):583-8. PubMed ID: 7690450
[TBL] [Abstract][Full Text] [Related]
28. Allosteric interaction of the neuromuscular blockers vecuronium and pancuronium with recombinant human muscarinic M2 receptors.
Cembala TM; Forde SC; Appadu BL; Lambert DG
Eur J Pharmacol; 2007 Aug; 569(1-2):37-40. PubMed ID: 17588565
[TBL] [Abstract][Full Text] [Related]
29. First gallamine-tacrine hybrid: design and characterization at cholinesterases and the M2 muscarinic receptor.
Elsinghorst PW; Cieslik JS; Mohr K; Tränkle C; Gütschow M
J Med Chem; 2007 Nov; 50(23):5685-95. PubMed ID: 17944454
[TBL] [Abstract][Full Text] [Related]
30. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
[TBL] [Abstract][Full Text] [Related]
31. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.
Ehlert FJ; Jenden DJ
Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562
[TBL] [Abstract][Full Text] [Related]
32. Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.
Narayanan TK; Aronstam RS
Neurochem Res; 1986 Oct; 11(10):1397-406. PubMed ID: 3785535
[TBL] [Abstract][Full Text] [Related]
33. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.
Tränkle C; Weyand O; Schröter A; Mohr K
Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401
[TBL] [Abstract][Full Text] [Related]
34. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.
Waelbroeck M
Mol Pharmacol; 1994 Oct; 46(4):685-92. PubMed ID: 7969047
[TBL] [Abstract][Full Text] [Related]
35. On the interaction of gallamine with muscarinic receptor subtypes.
Michel AD; Delmendo RE; Lopez M; Whiting RL
Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
[TBL] [Abstract][Full Text] [Related]
36. An unusual form of the association binding kinetics of N-[3H]methylscopolamine to the split muscarinic M2trunk/M2tail receptor.
Novi F; Scarselli M; Corsini GU; Maggio R
J Pharmacol Exp Ther; 2003 May; 305(2):786-95. PubMed ID: 12606698
[TBL] [Abstract][Full Text] [Related]
37. Allosteric interactions with muscarinic acetylcholine receptors: complex role of the conserved tryptophan M2422Trp in a critical cluster of amino acids for baseline affinity, subtype selectivity, and cooperativity.
Prilla S; Schrobang J; Ellis J; Höltje HD; Mohr K
Mol Pharmacol; 2006 Jul; 70(1):181-93. PubMed ID: 16641315
[TBL] [Abstract][Full Text] [Related]
38. Site-directed mutagenesis of the human A1 adenosine receptor: influences of acidic and hydroxy residues in the first four transmembrane domains on ligand binding.
Barbhaiya H; McClain R; Ijzerman A; Rivkees SA
Mol Pharmacol; 1996 Dec; 50(6):1635-42. PubMed ID: 8967987
[TBL] [Abstract][Full Text] [Related]
39. Search for lead structures to develop new allosteric modulators of muscarinic receptors.
Tränkle C; Kostenis E; Burgmer U; Mohr K
J Pharmacol Exp Ther; 1996 Nov; 279(2):926-33. PubMed ID: 8930201
[TBL] [Abstract][Full Text] [Related]
40. Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors.
Gnagey A; Ellis J
Biochem Pharmacol; 1996 Dec; 52(11):1767-75. PubMed ID: 8986140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
